Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
7,354,969
-
Total 13F shares
-
9,915,066
-
Share change
-
+916,056
-
Total reported value
-
$175,891,040
-
Price per share
-
$17.74
-
Number of holders
-
50
-
Value change
-
+$12,160,103
-
Number of buys
-
40
-
Number of sells
-
10
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) as of Q1 2019
As of 31 Mar 2019,
Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,915,066 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, BB BIOTECH AG, EcoR1 Capital, LLC, BlackRock Inc., COWEN INC., VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, FRANKLIN RESOURCES INC, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
50
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.